Beijing Tong Ren Tang Chinese Medicine Co (3613) Financial Statements

2 Followers

Beijing Tong Ren Tang Chinese Medicine Co Financial Overview

Beijing Tong Ren Tang Chinese Medicine Co's market cap is currently HK$5.98B. The company's EPS TTM is HK$0.377; its P/E ratio is 21.81; and it has a dividend yield of 4.04%. Beijing Tong Ren Tang Chinese Medicine Co is scheduled to report earnings on March 20, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	HK$ 1.51B	HK$ 1.61B	HK$ 1.52B	HK$ 1.73B	HK$ 1.56B
Gross Profit	HK$ 925.58M	HK$ 1.07B	HK$ 1.05B	HK$ 1.15B	HK$ 1.12B
Operating Income	HK$ 472.24M	HK$ 576.92M	HK$ 624.15M	HK$ 811.58M	HK$ 778.46M
EBITDA	HK$ 495.52M	HK$ 722.32M	HK$ 779.54M	HK$ 907.63M	HK$ 852.81M
Net Income	HK$ 397.22M	HK$ 500.28M	HK$ 540.39M	HK$ 645.88M	HK$ 607.84M
Balance Sheet
Cash & Short-Term Investments	HK$ 2.28B	HK$ 1.82B	HK$ 2.38B	HK$ 2.24B	HK$ 2.28B
Total Assets	HK$ 4.66B	HK$ 4.56B	HK$ 4.43B	HK$ 4.23B	HK$ 3.83B
Total Debt	HK$ 126.54M	HK$ 123.42M	HK$ 131.81M	HK$ 103.08M	HK$ 128.48M
Net Debt	HK$ -2.10B	HK$ -1.65B	HK$ -868.00M	HK$ -1.89B	HK$ -1.53B
Total Liabilities	HK$ 291.88M	HK$ 313.09M	HK$ 413.75M	HK$ 486.49M	HK$ 295.48M
Stockholders' Equity	HK$ 4.19B	HK$ 4.08B	HK$ 3.87B	HK$ 3.60B	HK$ 3.42B
Cash Flow
Free Cash Flow	HK$ 827.05M	HK$ -260.42M	HK$ 438.96M	HK$ 508.94M	HK$ 753.74M
Operating Cash Flow	HK$ 868.23M	HK$ -217.25M	HK$ 460.83M	HK$ 547.44M	HK$ 777.17M
Investing Cash Flow	HK$ -37.73M	HK$ 1.35B	HK$ -1.08B	HK$ 335.41M	HK$ -265.73M
Financing Cash Flow	HK$ -381.05M	HK$ -355.30M	HK$ -372.18M	HK$ -535.42M	HK$ -278.65M

Currency in HKD

Beijing Tong Ren Tang Chinese Medicine Co Earnings and Revenue History

Income Statement >

Beijing Tong Ren Tang Chinese Medicine Co Debt to Assets

Balance Sheet >

Beijing Tong Ren Tang Chinese Medicine Co Cash Flow

Cash Flow >

Beijing Tong Ren Tang Chinese Medicine Co Forecast EPS vs Actual EPS

Earnings >